Yin et al. demonstrated the dose-dependent pro-apoptotic efficacy of curcumin in SKOV-3 ovarian cancer cells partly due to the activation of RhoA/Rho-kinase signaling, which may, in part, explain some postulated beneficial effects of curcumin in the therapy of ovarian cancer [177]. The gene discussed is RHOA; the disease is ovarian carcinoma.